Stephen F. Betz serves as Executive at Crinetics Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Stephen F. Betz has executed 55 insider transactions totaling $5.0M, demonstrating a bearish approach to their equity position. Their most recent transaction on Nov 8, 2021 involved selling 3,900 shares valued at $110.8K.
Stephen F. Betz currently holds 117,713 shares of Crinetics Pharmaceuticals, Inc. (CRNX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Stephen F. Betz has been a net seller of CRNX stock. They have purchased $0 and sold $5.0M worth of shares.
Stephen F. Betz's most recent insider trade was on Nov 8, 2021, when they sold 3,900 shares at $28.42 per share.
Get notified when new Form 4 filings are submitted
| $27.95 |
| Discretionary |
| Nov 1, 2021 | CRNX | $140.5K | Sale | 5,668 | $24.79 | Discretionary |
| Oct 27, 2021 | CRNX | $72.0K | Sale | 3,000 | $24.00 | Discretionary |
| Oct 21, 2021 | CRNX | $22.0K | Sale | 1,042 | $21.10 | Discretionary |